Lamotrigine, sold as the brand name Lamictal among others, is an anticonvulsant medication used to treat epilepsy and to delay or prevent the recurrence of depressive episodes in bipolar disorder. For epilepsy, this includes focal seizures, tonic-clonic seizures, and seizures in Lennox-Gastaut syndrome
Anant Labs manufacture and furnish high quality Lamotrigine impurities for global markets. Our Lamotrigine EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diaminelamotrigine84057-84-1LamictalLamictal CdLamotriginaLamictal XRLamotriginumBW 430C3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazineBW-430CLamictal ODT1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazineBW430CDTXSID2023195NSC-759171SUBVENITEGW 273293U3H27498KSCHEBI:6367DTXCID203195LamotirigineLamotrigine ERLAMOTRIGINE KitRefChem:5936lamotrigine extended-releaseLamotrigine Extended Releaselamotrigine chewable dispersibleN03AX09281-901-8658-035-8Lamotriginum [Latin]Lamotrigina [Spanish]LabilenoLamitorC9H7Cl2N5MFCD00865333LTG;BW430CCHEMBL741MLS000069685s3024NCGC00015605-06LamictinSMR0000584646-(2,3-Dichloro-phenyl)-[1,2,4]triazine-3,5-diamine(6M)-6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamineLamictal (TN)CAS-84057-84-1SR-01000000187EINECS 281-901-8EpilepaxUNII-U3H27498KSLamictal;Lamotrigine CRSHSDB 7526EUR-1048IYJLamotrigine [USAN:USP:INN:BAN]Opera_ID_12Lamotrigine (Standard)Tocris-1611Lamotrigine 100 microg/mL in AcetonitrileLAMOTRIGINE [MI]LAMOTRIGINE [INN]LAMOTRIGINE [JAN]Lopac-L-3791LAMOTRIGINE [HSDB]LAMOTRIGINE [USAN]L 3791LAMOTRIGINE [MART.]Lopac0_000688SCHEMBL35439LAMOTRIGINE [USP-RS]LAMOTRIGINE [WHO-DD]MLS000759486MLS001077325MLS001423991BIDD:GT0794Lamotrigine (JAN/USP/INN)Lamotrigine, >=98%, powderGTPL2622orb1310392orb3141187Lamotrigine, 1mg/ml in EthanolLamotrigine - Bio-X trade markSCHEMBL29360953SCHEMBL29801510HY-B0495RLAMOTRIGINE [EP IMPURITY]LAMOTRIGINE [ORANGE BOOK]GLXC-07355HMS2051C10HMS2089M08HMS2093P21HMS2230L04HMS3262I17HMS3268G17HMS3371O16HMS3393C10HMS3657A17HMS3715H21HMS3885M03HMS5081I06LAMOTRIGINE [EP MONOGRAPH]LAMOTRIGINE [USP IMPURITY]Pharmakon1600-01505610LAMOTRIGINE [USP MONOGRAPH]HY-B0495Lamotrigine 1.0 mg/ml in MethanolMSK10267Tox21_110179Tox21_500688BDBM50031299EBC-03614HB0368NSC746307NSC759171STK628377AKOS005561147Lamotrigine for system suitability CRSTox21_110179_16-(2,2,4-triazine-3,5-diyldiamineCCG-100856DB00555ID58057KS-1074Lamotrigine for peak identification CRSLP00688NC00106NSC 746307NSC 759171NSC-746307SDCCGSBI-0050666.P003SMP2_000303NCGC00015605-01NCGC00015605-02NCGC00015605-03NCGC00015605-04NCGC00015605-05NCGC00015605-07NCGC00015605-08NCGC00015605-09NCGC00015605-10NCGC00015605-23NCGC00015605-24NCGC00022936-02NCGC00022936-04NCGC00022936-05NCGC00261373-01AC-10298AC-32483BL166799SBI-0050666.P002DB-014839EU-0100688L0241NS00000354SW197486-3D00354EN300-120680W13018AB00384359-16AB00384359_17AB00384359_18F093440Q4103463,5-diamino-(2,3-dichlorophenyl)-1,2,4-triazineSR-01000000187-2SR-01000000187-4SR-01000000187-7BRD-K93460210-001-22-9BRD-K93460210-001-23-7BRD-K93460210-071-01-6SR-01000000187-103,5-diamino-6-(2,3,-dichlorophenyl)-1,2,4-triazineF2173-0540Z1532338577Lamotrigine Working Standard (Secondary Reference Standard)Lamotrigine, British Pharmacopoeia (BP) Reference StandardLamotrigine, European Pharmacopoeia (EP) Reference Standard1,2,4-TRIAZINE-3,5-DIAMINE, 6-(2,3-DICHLOROPHENYL)6-(2,3-Dichloro-phenyl)-[1,2,4]triazine-3,5-diamine(lamotrigine)GI 267119X; 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamineLamotrigine, United States Pharmacopeia (USP) Reference StandardLamotrigine, Pharmaceutical Secondary Standard; Certified Reference MaterialLamotrigine for peak identification, European Pharmacopoeia (EP) Reference StandardLamotrigine for system suitability, European Pharmacopoeia (EP) Reference Standard
